Lim, Jennifer I <br/><br/>
One-year results of a pilot study using oral 13-cis retinoic acid as a treatment for subfoveal predominantly occult choroidal neovascularization in patients with age-related macular degeneration.  [electronic resource] 

 -  Retina (Philadelphia, Pa.)  Mar 2006 
 - 314-21 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0275-004X 
<br/><br/><label>Standard No.: </label>10.1097/00006982-200603000-00010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Aged<br/>Aged, 80 and over<br/>Choroidal Neovascularization--drug therapy<br/>Female<br/>Fluorescein Angiography<br/>Follow-Up Studies<br/>Fovea Centralis<br/>Humans<br/>Isotretinoin--adverse effects<br/>Macular Degeneration--complications<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Treatment Outcome<br/>Visual Acuity--drug effects